Lamivudine 3TC Tablets Ref.[49697] Active ingredients: Lamivudine

Source: Health Products and Food Branch (CA)  Revision Year: 2022 

Product name

3TC – Antiretroviral agent.

Lamivudine tablets, 150 mg, oral.
Lamivudine tablets, 300 mg, oral.
Lamivudine oral solution, 10 mg/mL.

Summary product information

Dosage forms, composition and packaging

Table 4. Dosage Forms, Strengths, Composition and Packaging:

Route of AdministrationDosage Form / Strength/CompositionNon-medicinal Ingredients
OralTablets/150 mghydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate and titanium dioxide
Tablets/300 mgblack iron oxide, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate and titanium dioxide
Oral Solution/10 mg/mLartificial strawberry and banana flavours, citric acid (anhydrous), hydrochloric acid, methylparaben, propylparaben, propylene glycol, sodium citrate (dihydrate), sodium hydroxide, sucrose and water. Each 150 mg (15 mL) contains 3 g of sucrose

Dosage Forms

Tablets

3TC tablets 150 mg are white, modified diamond-shaped, scored, film-coated tablets and imprinted with “GX CJ7” on both faces. 3TC tablets 300 mg are grey, modified diamond-shaped, film-coated tablets and imprinted with “GX EJ7” on one face.

Oral Solution

3TC oral solution is a colourless to pale yellow, strawberry-banana flavour, clear liquid.

Packaging

Tablets

150 mg: Supplied in bottles of 60 tablets

300 mg: Supplied in bottles of 30 tablets.

Oral Solution

Supplied in 240 mL plastic bottles.

Marketing Informations Authorization Dates
Authorization holder:

ViiV Healthcare ULC, 75 Rue Queen, Suite 1400, Montreal, Quebec, H3C 2N6

Submission control number:

249461

Date of approval:

December 08, 1995

Date of revision:

January 21, 2022

Drugs

Drug Countries
3TC Australia, Canada, Hong Kong, New Zealand

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.